A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males

Completed · Phase 3

Conditions studied: Adult Male Hypogonadism

In brief

This is a phase 3, open-label, non-randomized, clinical trial to evaluate the efficacy and safety of FE 999303 (Testosterone gel) in adult hypogonadal males.

Key facts

Study ID
NCT02149264
Run by
Ferring Pharmaceuticals
People needed
160
Starts
2014-07-01
Expected to finish
2015-06-01
Last updated by the study team
2017-10-26

Who can join

Age: 18 and older, up to 75. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.